EP3082857
COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.12.2014EP published:
25.7.2018EP application number:
14821592.4
EPO information:
European Patent Register
Max expiry date:
16.12.2034
Title:
COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
Timeline
Today
17.12.2014EP application
25.7.2018EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacher Strasse 124, 4070, Basel, CH
Inventor
Name:
KLEIN, ChristianAddress:
Bonstetten, CH
Name:
MUELLER, PhilippAddress:
Biberach an der Riss, DE
Name:
THOMAS, MarkusAddress:
Rheinfelden, DE
Name:
ZIPPELIUS, AlfredAddress:
Basel, CH
Priority
Number:
13198753Date:
20.12.2013Country:
EP
Number:
14158331Date:
7.3.2014Country:
EP
Classification
Categories:
A61K 39/395, C07K 16/22, C07K 16/28, A61K 39/00